Global Colon Cancer Molecular Diagnostics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Market Analysis by Type
1.3.1 Global Colon Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.3.2 PCR
1.3.3 FISH
1.3.4 DNA Sequencing
1.3.5 Gene Chip
1.4 Market by Application
1.4.1 Global Colon Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2026
1.4.2 Clinical Diagnosis
1.4.3 Drug Screening
1.4.4 Research
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colon Cancer Molecular Diagnostics Market Perspective (2015-2026)
2.2 Colon Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Colon Cancer Molecular Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Colon Cancer Molecular Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Colon Cancer Molecular Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Colon Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Colon Cancer Molecular Diagnostics Market Trends
2.3.2 Colon Cancer Molecular Diagnostics Market Drivers
2.3.3 Colon Cancer Molecular Diagnostics Market Challenges
2.3.4 Colon Cancer Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colon Cancer Molecular Diagnostics Players by Market Size
3.1.1 Global Top Colon Cancer Molecular Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Colon Cancer Molecular Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global Colon Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colon Cancer Molecular Diagnostics Revenue
3.4 Global Colon Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Colon Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colon Cancer Molecular Diagnostics Revenue in 2019
3.5 Key Players Colon Cancer Molecular Diagnostics Area Served
3.6 Key Players Colon Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Colon Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colon Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Colon Cancer Molecular Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Type (2021-2026)
5 Colon Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Colon Cancer Molecular Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Colon Cancer Molecular Diagnostics Market Size (2015-2026)
6.2 North America Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020)
6.3 North America Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020)
6.4 North America Colon Cancer Molecular Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Colon Cancer Molecular Diagnostics Market Size (2015-2026)
7.2 Europe Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020)
7.3 Europe Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020)
7.4 Europe Colon Cancer Molecular Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size (2015-2026)
8.2 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020)
8.3 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020)
8.4 Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
9 Latin America
9.1 Latin America Colon Cancer Molecular Diagnostics Market Size (2015-2026)
9.2 Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020)
9.3 Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020)
9.4 Latin America Colon Cancer Molecular Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size (2015-2026)
10.2 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020)
10.3 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020)
10.4 Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11Key Players Profiles
11.1 Kingmed
11.1.1 Kingmed Company Details
11.1.2 Kingmed Business Overview
11.1.3 Kingmed Colon Cancer Molecular Diagnostics Introduction
11.1.4 Kingmed Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020))
11.1.5 Kingmed Recent Development
11.2 Geneis
11.2.1 Geneis Company Details
11.2.2 Geneis Business Overview
11.2.3 Geneis Colon Cancer Molecular Diagnostics Introduction
11.2.4 Geneis Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.2.5 Geneis Recent Development
11.3 Unitedgene
11.3.1 Unitedgene Company Details
11.3.2 Unitedgene Business Overview
11.3.3 Unitedgene Colon Cancer Molecular Diagnostics Introduction
11.3.4 Unitedgene Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.3.5 Unitedgene Recent Development
11.4 Yin Feng Gene
11.4.1 Yin Feng Gene Company Details
11.4.2 Yin Feng Gene Business Overview
11.4.3 Yin Feng Gene Colon Cancer Molecular Diagnostics Introduction
11.4.4 Yin Feng Gene Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.4.5 Yin Feng Gene Recent Development
11.5 Inmedi
11.5.1 Inmedi Company Details
11.5.2 Inmedi Business Overview
11.5.3 Inmedi Colon Cancer Molecular Diagnostics Introduction
11.5.4 Inmedi Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.5.5 Inmedi Recent Development
11.6 ApexHealth
11.6.1 ApexHealth Company Details
11.6.2 ApexHealth Business Overview
11.6.3 ApexHealth Colon Cancer Molecular Diagnostics Introduction
11.6.4 ApexHealth Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.6.5 ApexHealth Recent Development
11.7 Amoydx
11.7.1 Amoydx Company Details
11.7.2 Amoydx Business Overview
11.7.3 Amoydx Colon Cancer Molecular Diagnostics Introduction
11.7.4 Amoydx Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.7.5 Amoydx Recent Development
11.8 Genetronhealth
11.8.1 Genetronhealth Company Details
11.8.2 Genetronhealth Business Overview
11.8.3 Genetronhealth Colon Cancer Molecular Diagnostics Introduction
11.8.4 Genetronhealth Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.8.5 Genetronhealth Recent Development
11.9 Berryoncology
11.9.1 Berryoncology Company Details
11.9.2 Berryoncology Business Overview
11.9.3 Berryoncology Colon Cancer Molecular Diagnostics Introduction
11.9.4 Berryoncology Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.9.5 Berryoncology Recent Development
11.10 Topgen
11.10.1 Topgen Company Details
11.10.2 Topgen Business Overview
11.10.3 Topgen Colon Cancer Molecular Diagnostics Introduction
11.10.4 Topgen Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
11.10.5 Topgen Recent Development
11.11 Roche
10.11.1 Roche Company Details
10.11.2 Roche Business Overview
10.11.3 Roche Colon Cancer Molecular Diagnostics Introduction
10.11.4 Roche Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
10.11.5 Roche Recent Development
11.12 Qiagen
10.12.1 Qiagen Company Details
10.12.2 Qiagen Business Overview
10.12.3 Qiagen Colon Cancer Molecular Diagnostics Introduction
10.12.4 Qiagen Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020)
10.12.5 Qiagen Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Colon Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Colon Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Colon Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Colon Cancer Molecular Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Colon Cancer Molecular Diagnostics Market Share by Regions (2015-2020)
Table 10. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Colon Cancer Molecular Diagnostics Market Share by Regions (2021-2026)
Table 12. Colon Cancer Molecular Diagnostics Market Market Trends
Table 13. Colon Cancer Molecular Diagnostics Market Drivers
Table 14. Colon Cancer Molecular Diagnostics Market Challenges
Table 15. Colon Cancer Molecular Diagnostics Market Restraints
Table 16. Global Colon Cancer Molecular Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Colon Cancer Molecular Diagnostics Market Share by Players (2015-2020)
Table 18. Global Top Colon Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon Cancer Molecular Diagnostics as of 2019)
Table 19. Global Colon Cancer Molecular Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Colon Cancer Molecular Diagnostics Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Type (2015-2020)
Table 25. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Type (2021-2026) (US$ Million)
Table 26. Global Colon Cancer Molecular Diagnostics Market Size Share by Application (2015-2020) (US$ Million)
Table 27. Global Colon Cancer Molecular Diagnostics Revenue Market Share by Application (2015-2020)
Table 28. Global Colon Cancer Molecular Diagnostics Forecasted Market Size by Application (2021-2026) (US$ Million)
Table 29. North America Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Colon Cancer Molecular Diagnostics Market Share by Type (2015-2020)
Table 31. North America Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Colon Cancer Molecular Diagnostics Market Share by Application (2015-2020)
Table 33. North America Colon Cancer Molecular Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Colon Cancer Molecular Diagnostics Market Share by Country (2015-2020)
Table 35. Europe Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Colon Cancer Molecular Diagnostics Market Share by Type (2015-2020)
Table 37. Europe Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Colon Cancer Molecular Diagnostics Market Share by Application (2015-2020)
Table 39. Europe Colon Cancer Molecular Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Colon Cancer Molecular Diagnostics Market Share by Country (2015-2020)
Table 41. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 42. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Type (2015-2020)
Table 43. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 44. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Application (2015-2020)
Table 45. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 46. Asia-Pacific Colon Cancer Molecular Diagnostics Market Share by Region (2015-2020)
Table 47. Latin America Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 48. Latin America Colon Cancer Molecular Diagnostics Market Share by Type (2015-2020)
Table 49. Latin America Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 50. Latin America Colon Cancer Molecular Diagnostics Market Share by Application (2015-2020)
Table 51. Latin America Colon Cancer Molecular Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 52. Latin America Colon Cancer Molecular Diagnostics Market Share by Country (2015-2020)
Table 53. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 54. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Type (2015-2020)
Table 55. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 56. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Application (2015-2020)
Table 57. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 58. Middle East & Africa Colon Cancer Molecular Diagnostics Market Share by Country (2015-2020)
Table 59. Kingmed Company Details
Table 60. Kingmed Business Overview
Table 61. Kingmed Colon Cancer Molecular Diagnostics Product
Table 62. Kingmed Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 63. Kingmed Recent Development
Table 64. Geneis Company Details
Table 65. Geneis Business Overview
Table 66. Geneis Colon Cancer Molecular Diagnostics Product
Table 67. Geneis Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 68. Geneis Recent Development
Table 69. Unitedgene Company Details
Table 70. Unitedgene Business Overview
Table 71. Unitedgene Colon Cancer Molecular Diagnostics Product
Table 72. Unitedgene Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 73. Unitedgene Recent Development
Table 74. Yin Feng Gene Company Details
Table 75. Yin Feng Gene Business Overview
Table 76. Yin Feng Gene Colon Cancer Molecular Diagnostics Product
Table 77. Yin Feng Gene Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 78. Yin Feng Gene Recent Development
Table 79. Inmedi Company Details
Table 80. Inmedi Business Overview
Table 81. Inmedi Colon Cancer Molecular Diagnostics Product
Table 82. Inmedi Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 83. Inmedi Recent Development
Table 84. ApexHealth Company Details
Table 85. ApexHealth Business Overview
Table 86. ApexHealth Colon Cancer Molecular Diagnostics Product
Table 87. ApexHealth Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 88. ApexHealth Recent Development
Table 89. Amoydx Company Details
Table 90. Amoydx Business Overview
Table 91. Amoydx Colon Cancer Molecular Diagnostics Product
Table 92. Amoydx Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 93. Amoydx Recent Development
Table 94. Genetronhealth Business Overview
Table 95. Genetronhealth Colon Cancer Molecular Diagnostics Product
Table 96. Genetronhealth Company Details
Table 97. Genetronhealth Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 98. Genetronhealth Recent Development
Table 99. Berryoncology Company Details
Table 100. Berryoncology Business Overview
Table 101. Berryoncology Colon Cancer Molecular Diagnostics Product
Table 102. Berryoncology Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 103. Berryoncology Recent Development
Table 104. Topgen Company Details
Table 105. Topgen Business Overview
Table 106. Topgen Colon Cancer Molecular Diagnostics Product
Table 107. Topgen Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 108. Topgen Recent Development
Table 109. Roche Company Details
Table 110. Roche Business Overview
Table 111. Roche Colon Cancer Molecular Diagnostics Product
Table 112. Roche Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 113. Roche Recent Development
Table 114. Qiagen Company Details
Table 115. Qiagen Business Overview
Table 116. Qiagen Colon Cancer Molecular Diagnostics Product
Table 117. Qiagen Revenue in Colon Cancer Molecular Diagnostics Business (2015-2020) (US$ Million)
Table 118. Qiagen Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Colon Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Colon Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Colon Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Colon Cancer Molecular Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Colon Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Colon Cancer Molecular Diagnostics Market Share by Regions (2021-2026)
Figure 14. Global Colon Cancer Molecular Diagnostics Market Share by Players in 2019
Figure 15. Global Top Colon Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colon Cancer Molecular Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Colon Cancer Molecular Diagnostics Revenue in 2019
Figure 17. North America Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Colon Cancer Molecular Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Kingmed Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 43. Geneis Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 44. Unitedgene Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 45. Yin Feng Gene Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 46. Inmedi Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 47. ApexHealth Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 48. Amoydx Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 49. Genetronhealth Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 50. Berryoncology Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 51. Topgen Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 52. Roche Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 53. Qiagen Revenue Growth Rate in Colon Cancer Molecular Diagnostics Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed